Dajun Yang
Co-Founder, Chairman & CEODr. Dajun Yang, M.D., Ph.D, co-founded Ascentage Pharma Group International in 2009 and serves as its Chairman from 2017 and has been its Director since November 17, 2017 and serves as its CEO since 2009. His Roles and responsibilities as Strategic planning and business direction, overall management of the business of the Group. Dr. Yang is also a director of each of Ascentage Pharma (HK), Ascentage Jiangsu, Ascentage International, Ascentage Suzhou, Ascentage Shanghai, Ascentage Australia and Ascentage US. Dr. Yang is the spouse of Dr. Zhai, chief medical officer and a member of the senior management. Prior to founding the Group in 2009, Dr. Yang has worked in the following companies. Dr. Yang was an associate professor of biochemistry and molecular biology (June 1995 to June 1999) and oncology (July 1999 to May 2001) and senior investigator of the Lombardi Cancer Center at the medical center of Georgetown University. Dr. Yang co-founded Ascenta Therapeutics, Inc., where he was a senior vice president of research and preclinical development between 2004 and 2008. Ascenta Therapeutics, Inc. was dissolved in January 2017. Dr. Yang was the principal responsible person for establishing Ascenta R&D Center in Shanghai as a wholly-owned subsidiary of Ascenta Therapeutics, Inc. and served as the first general manager and a member of its board of directors between 2005 and 2008. Dr. Yang served as a part-time professor and supervisor of doctoral students at Cancer Center at Sun Yat-sen University from September 2003 to September 2006. Dr. Yang was appointed as the vice president of Biology of S*BIO Ltd Pte, a Singapore-Chiron joint venture from 2002 to 2003. Dr. Yang is the author or co-author of 92 publications and the inventor of 14 patents. He was a co-founder, chief staff writer and editor for two national magazines in China, namely “Chinese Medical Students” and “Family Doctors”. Nowadays “Family Doctors” has a monthly publication volume of over one million and it has the mission to promote both healthcare and a healthy lifestyle in China. Dr. Yang obtained his Bachelor’s degree of medicine and Master’s degree in Oncology from Sun Yat-sen University of Medical Sciences (now renamed as the Sun Yat-sen University in July 1983 and June 1986 respectively and he received a Ph.D. degree in Genetics Michigan State University in the United States in June 1992.
Positions
- Company NameAscentage Pharma Group InternationalStock Code06855PositionCo-Founder, Chairman & CEORelated SecuritiesColleagues
- SWShaomeng WangCo-Founder, Chief Scientific Advisor & Non-Executive Director
- MGMing GuoCo-Founder
- VMVeet MisraChief Financial Officer
- YCYuly ChenSenior Director of Investor Relations
- CYChangqing YeIndependent Non-Executive Director
- ASAllen S. LichterChairman of the Clinical Advisory Board
- WRWei RenIndependent Non-Executive Director
